These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6308330)

  • 21. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association among C4d staining in renal transplant biopsies, the production of donor-specific HLA antibodies, and graft outcome.
    Howie AJ
    Transplantation; 2007 Feb; 83(4):373-4. PubMed ID: 17318067
    [No Abstract]   [Full Text] [Related]  

  • 23. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
    Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
    Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of frozen blood transfusions on renal allograft survival.
    Fuller TC; Burroughs JC; Delmonico FL; Rubin NT; Cosimi AB; Russell PS
    Transplant Proc; 1982 Jun; 14(2):293-5. PubMed ID: 7051469
    [No Abstract]   [Full Text] [Related]  

  • 25. Risk factors for chronic transplant failure after kidney transplantation.
    Hofmann GO; Schneeberger H; Land W
    Transplant Proc; 1995 Jun; 27(3):2031-2. PubMed ID: 7792875
    [No Abstract]   [Full Text] [Related]  

  • 26. Detailed examination of HLA antibody development on renal allograft failure and function.
    Zhu L; Lee PC; Everly MJ; Terasaki PI
    Clin Transpl; 2008; ():171-87. PubMed ID: 19711514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum thymidine-kinase and cytomegalovirus-specific antibodies after renal transplantation.
    Tufveson G; Tötterman TH; Källander CF; Hagström A; Gronowitz JS
    Transplant Proc; 1988 Jun; 20(3):405-7. PubMed ID: 2837850
    [No Abstract]   [Full Text] [Related]  

  • 28. Renal changes in cytomegalovirus infection.
    Castro LA; Gokel JM; Thoenes G; Frösner G; Land W; Hillebrand G; Gurland HJ
    Proc Eur Dial Transplant Assoc; 1983; 19():500-4. PubMed ID: 6308601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.
    Hourmant M; Cesbron-Gautier A; Terasaki PI; Mizutani K; Moreau A; Meurette A; Dantal J; Giral M; Blancho G; Cantarovich D; Karam G; Follea G; Soulillou JP; Bignon JD
    J Am Soc Nephrol; 2005 Sep; 16(9):2804-12. PubMed ID: 16014742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of the efficacy of cytomegalovirus immune globulin in the prophylaxis of CMV disease in renal transplant recipients.
    Snydman DR
    Transplant Proc; 1993 Oct; 25(5 Suppl 4):25-6. PubMed ID: 8212304
    [No Abstract]   [Full Text] [Related]  

  • 31. Successful kidney transplantation after loss of specific antidonor HLA antibodies.
    Schweizer RT; Bow LM
    Transplantation; 1983 Dec; 36(6):731-2. PubMed ID: 6362150
    [No Abstract]   [Full Text] [Related]  

  • 32. Beneficial effect of blood transfusion in HLA identical and haploidentical renal allografts.
    Kovithavongs T; Schlaut J; Marchuk L; Bettcher KB; Pazderka F; Dossetor JB
    Transplant Proc; 1982 Dec; 14(4):690-2. PubMed ID: 6762727
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of cytomegalovirus on renal transplantation.
    May AG; Betts RF; Andrus CC; Freeman RB; Hoy WE; Tibi PR; Carey AS
    N Y State J Med; 1982 Jul; 82(8):1199-206. PubMed ID: 6290953
    [No Abstract]   [Full Text] [Related]  

  • 34. Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation.
    Fan J; Meng XQ; Yang MF; Zhou L; Chen XM; Hu MJ; Fan WW; Ma WH; Li LJ
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):34-8. PubMed ID: 16481279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [HLA compatibility and antigenic re-exposure. Impact on the clinical course of cadaver kidney transplantation].
    Fernández Aparicio T; Miñana López B; Polo Villar G; Diaz González R; Fraile Gómez B; Aguirre Benites F; Morales Cerdán JM; Leiva Galvis O
    Arch Esp Urol; 2000; 53(1):53-64. PubMed ID: 10730425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
    Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
    Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure.
    Cai J; Terasaki PI; Anderson N; Lachmann N; Schönemann C
    Transplantation; 2009 Jul; 88(2):226-30. PubMed ID: 19623018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
    Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-kidney-transplant blood transfusions do not improve transplantation outcome: a Dutch national study.
    Aalten J; Bemelman FJ; van den Berg-Loonen EM; Claas FH; Christiaans MH; de Fijter JW; Hepkema BG; Hené RJ; van der Heide JJ; van Hooff JP; Lardy NM; Lems SP; Otten HG; Weimar W; Allebes WA; Hoitsma AJ
    Nephrol Dial Transplant; 2009 Aug; 24(8):2559-66. PubMed ID: 19474284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
    Worthington JE; Martin S; Al-Husseini DM; Dyer PA; Johnson RW
    Transplantation; 2003 Apr; 75(7):1034-40. PubMed ID: 12698094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.